Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response-Reference-Cited by-同舟云学术

Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response

Published:2018-07-11 Issue:1 Volume:2 Page:
ISSN:2397-768X
Container-title:npj Precision Oncology
language:en
Short-container-title:npj Precision Onc

Author:

Vargas Roberto,Gopal Priyanka,Kuzmishin Gwendolyn B.,DeBernardo Robert,Koyfman Shlomo A.,Jha Babal K.,Mian Omar Y.,Scott Jacob^ORCID,Adams Drew J.,Peacock Craig D.,Abazeed Mohamed E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Computer Science Applications,History,Education

Link

http://www.nature.com/articles/s41698-018-0060-3.pdf

Reference34 articles.

1. Hidalgo, M. et al. Patient-derived xenograft models: an emerging platform for Translational Cancer Research. Cancer Discov. 4, 998–1013 (2014).

2. Tentler, J. J. et al. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 9, 338–350 (2012).

3. Gao, H. et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat. Med. 21, 1318–1325 (2015).

4. Hidalgo, M. et al. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol. Cancer Ther. 10, 1311–1316 (2011).

5. Garrido-Laguna, I. et al. Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin. Cancer Res. 17, 5793–5800 (2011).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma;Journal of Experimental & Clinical Cancer Research;2023-10-07

2. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice;Cancer Cell International;2023-06-21

3. Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy;Frontiers in Oncology;2023-04-04

4. Evolution-Informed Strategies for Combating Drug Resistance in Cancer;International Journal of Molecular Sciences;2023-04-04

5. The future of patient-derived xenografts in prostate cancer research;Nature Reviews Urology;2023-01-17